Cart
sales@molnova.com
Mopidamol
CAS No. 13665-88-8
Mopidamol( —— )
Catalog No. M34106 CAS No. 13665-88-8
Mopidamol (RA 233) is a phosphodiesterase inhibitor, a dipyridamole derivative, with anticancer activity that prevents retinal vascular defects in experimental diabetes.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 578 | Get Quote |
|
| 5MG | 845 | Get Quote |
|
| 10MG | 1169 | Get Quote |
|
| 25MG | 1684 | Get Quote |
|
| 50MG | 2006 | Get Quote |
|
| 100MG | 2520 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameMopidamol
-
NoteResearch use only, not for human use.
-
Brief DescriptionMopidamol (RA 233) is a phosphodiesterase inhibitor, a dipyridamole derivative, with anticancer activity that prevents retinal vascular defects in experimental diabetes.
-
DescriptionMopidamol (RA 233) is a phosphodiesterase inhibitor, a dipyridamole derivative, with anticancer activity that prevents retinal vascular defects in experimental diabetes.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayAngiogenesis
-
TargetPDE
-
RecptorPDE
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number13665-88-8
-
Formula Weight421.49
-
Molecular FormulaC19H31N7O4
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESN(CCO)(CCO)C1=NC=2C(=NC(N(CCO)CCO)=NC2C=N1)N3CCCCC3
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
BW-A78U
BW-A 78U is a PDE4 inhibitor (IC50: 3 μM). It is not inhibition on the lipopolysaccharide (LPS)-induced TNF-α release.
-
Cilostazol
Cilostazol (OPC 13013, OPC 21) is a potent inhibitor of PDE3A with IC50 of 0.2 uM; inhibits platelet aggregation and has considerable antithrombotic effects in vivo.
-
Filaminast
Filaminast (WAY-PDA-641;PDA-641;WAY-123641) is a potent and selective PDE4 inhibitor with IC50 of 420 nM, displays 36-fold selectivity over PDE3.
